Modeling Philadelphia chromosome positive leukemias (Q34405446)

2 August 2017

1 reference

title

Modeling Philadelphia chromosome positive leukemias (English)

1 reference

2 August 2017

Wong S

1

1 reference

2 August 2017

Witte ON

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

20

1 reference

2 August 2017

issue

40

1 reference

2 August 2017

page(s)

5644-5659

1 reference

Differential complementation of Bcr-Abl point mutants with c-Myc

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Regulation of the oncogenic activity of BCR-ABL by a tightly bound substrate protein RIN1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Signaling by ABL oncogenes through cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

A clonogenic common myeloid progenitor that gives rise to all myeloid lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

RETRACTED: Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Leukemia initiated by hemopoietic stem cells expressing the v-abl oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

New understanding of the pathogenesis of CML: a prototype of early neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

PU.1, interferon regulatory factor 1, and interferon consensus sequence-binding protein cooperate to increase gp91(phox) expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Hematologic disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Isolation of temperature-sensitive Abelson virus mutants by site-directed mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Regulated expression of P210 Bcr-Abl during embryonic stem cell differentiation stimulates multipotential progenitor expansion and myeloid cell fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Clonal origin of chronic myelocytic leukemia in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Bcr-Abl with an SH3 deletion retains the ability To induce a myeloproliferative disease in mice, yet c-Abl activated by an SH3 deletion induces only lymphoid malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Cytokine therapeutics: lessons from interferon alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

A bcr-v-abl oncogene induces lymphomas in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Acute leukaemia in bcr/abl transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Structural organization of the bcr gene and its role in the Ph' translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Reversibility of acute B-cell leukaemia induced by BCR-ABL1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Consequences of BCR-ABL expression within the hematopoietic stem cell in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

BCR/ABL inhibition by an escort/phosphatase fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

The dimerization property of glutathione S-transferase partially reactivates Bcr-Abl lacking the oligomerization domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Deletion of the ABL SH3 domain reactivates de-oligomerized BCR-ABL for growth factor independence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Myeloproliferative disorder and leukaemia in mice induced by different classes of constitutive mutants of the human IL-3/IL-5/GM-CSF receptor common beta subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

The cytogenetic scenario of chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Expression of c-jun, jun B and jun D proto-oncogenes in human peripheral-blood granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Generation of lymphohematopoietic cells from embryonic stem cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

SH1 domain autophosphorylation of P210 BCR/ABL is required for transformation but not growth factor independence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR/ABL-induced murine leukemia and primary cells from patients with chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

In vivo tyrosine phosphorylations of the abelson virus transforming protein are absent in its normal cellular homolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Treatment of Bcr/Abl-positive acute lymphoblastic leukemia in P190 transgenic mice with the farnesyl transferase inhibitor SCH66336.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

The src homology 2 domain of Bcr/Abl is required for efficient induction of chronic myeloid leukemia-like disease in mice but not for lymphoid leukemogenesis or activation of phosphatidylinositol 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

JunB is essential for mammalian placentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

v-abl causes hematopoietic disease distinct from that caused by bcr-abl

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Functional domain analysis of interferon consensus sequence binding protein (ICSBP) and its association with interferon regulatory factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Negative regulation of p120GAP GTPase promoting activity by p210bcr/abl: implication for RAS-dependent Philadelphia chromosome positive cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Blastic transformation of p53-deficient bone marrow cells by p210bcr/abl tyrosine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

p53 mediates apoptotic crisis in primary Abelson virus-transformed pre-B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Bcr/Abl associated leukemogenesis in bcr null mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Increased neutrophil respiratory burst in bcr-null mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

A transformation-defective mutant of Abelson murine leukemia virus lacks protein kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

The NH(2)-terminal coiled-coil domain and tyrosine 177 play important roles in induction of a myeloproliferative disease in mice by Bcr-Abl

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

The SH2 domain of bcr-Abl is not required to induce a murine myeloproliferative disease; however, SH2 signaling influences disease latency and phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

A model of human p210(bcr/ABL)-mediated chronic myelogenous leukemia by transduction of primary normal human CD34(+) cells with a BCR/ABL-containing retroviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

p53 deficiency increases transformation by v-Abl and rescues the ability of a C-terminally truncated v-Abl mutant to induce pre-B lymphoma in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Chronic Myeloid Leukemia with Increased Granulocyte Progenitors in Mice Lacking JunB Expression in the Myeloid Lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

A novel abl protein expressed in Philadelphia chromosome positive acute lymphoblastic leukaemia positive acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Novel chimaeric protein expressed in Philadelphia positive acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

Expression of BCR – ABL in M1 myeloid leukemia cells induces differentiation without arresting proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

7 January 2021

Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

7 January 2021

Presence of re-appearance of BCR-ABL-positive cells years after allogeneic bone marrow transplantation for chronic-phase chronic myelogenous leukemia in patients in hematological remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

7 January 2021

bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

7 January 2021

Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

7 January 2021

New insights into the biology of Philadelphia-chromosome-positive acute lymphoblastic leukaemia using a combination of May-Grünwald-Giemsa staining and fluorescence in situ hybridization techniques at the single cell level

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

7 January 2021

Humanbcr-abl gene has a lethal effect on embryogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

7 January 2021

Strategies for manipulating the p53 pathway in the treatment of human cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

7 January 2021

A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

7 January 2021

Investigation of clonal involvement of myeloid cells in Philadelphia-positive and high hyperdiploid acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

7 January 2021

Apoptotic Cell Death During Treatment of Leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

7 January 2021

Lack of correlation between ABL-BCR expression and response to interferon-alpha in chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

7 January 2021

Philadelphia chromosome positive B-cell type malignant lymphoma expressing an aberrant 190 kDa bcr-abl protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

7 January 2021

Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

7 January 2021

The existence of lymphoid lineage restricted Philadelphia chromosome-positive acute lymphoblastic leukemia with heterogeneous bcr-abl rearrangement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

7 January 2021

The viral and cellular forms of the Abelson (abl) oncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

7 January 2021

P53 tumor suppressor gene in chronic myelogenous leukemia: a sequential study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

7 January 2021

Early events in leukemogenesis in P190Bcr-abl transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

7 January 2021

The p53 tumor suppressor gene: from molecular biology to clinical investigation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

7 January 2021

Phosphorylation of the Abelson murine leukemia virus transforming protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204638

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204638

1 reference

Dimensions Publication ID

2 August 2017

1022494522

0 references

1 reference